Multiple outlets report that President Vladimir Putin is associated with a Russia-backed effort to extend human lifespan, described as a longevity program funded at about $26 billion. The reported research agenda includes a mix of advanced biomedical approaches and experiments, such as gene therapy aimed at slowing cellular aging, lab-grown or 3D-printed organs, and related medical technologies. Coverage also mentions cryotherapy and other extreme interventions, including frozen-chamber approaches, as part of the broader effort.
The outlets describe the initiative as state-supported and positioned as a Kremlin priority, while noting that details and scientific validation are contested. Some reporting emphasizes Putin’s personal interest in anti-aging research and portrays the program as an attempt to overcome the effects of aging at a national level. Other sources highlight skepticism from critics who question whether the proposed methods are scientifically proven or translate into measurable health outcomes.
Separately, the reporting situates the push within broader demographic and health context in Russia, including concerns about life expectancy. All accounts agree on the core figure cited for funding and the high-profile range of longevity-related technologies being explored.
